Corporate Banner
Satellite Banner
Technology Networks Header
Friday, December 19, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
Bio-Rad Launches Easy-to-Use PureBlu™ Nuclear Staining Dyes
Tuesday, December 16, 2014
High purity, pre-aliquoted formulations for cell imaging experiments.

Leica Microsystems Previews Light Sheet Module for Confocal Microscope
Tuesday, December 09, 2014
Technology preview at ASCB annual meeting.

Consistent Embryoid Body Formation and Differentiation from Stem Cells
Tuesday, December 02, 2014
Cultrex® Embryoid Body Formation Kit from AMSBIO.

Quick Evaluation with New UNICORN™ 7.0 Software
Wednesday, November 26, 2014
The software controls protein purification runs as well as cell culture and preparation.

VivaFix™ Cell Viability Assays Launched
Monday, November 24, 2014
Bio-Rad introduces a simple way to assess the viability of cells for flow cytometry and cell sorting that is compatible with fixation.

Organovo Announces Commercial Release of the exVive3D™ Human Liver Tissue
Friday, November 21, 2014
exVive3D™ human liver tissue for preclinical drug discovery testing.

Bio-Rad Launches Benchtop S3e™ Cell Sorter with AutoGimbal™ Nozzle Alignment System
Thursday, November 20, 2014
Walk-away automation for accurate and reliable cell sorts of one or two populations.

New ambr® 15 Webinar on Overcoming Bottlenecks in Cell Line Development
Wednesday, November 19, 2014
Features data showing how this technology can improve biologics manufacturing.

Irvine Scientific Introduces DMSO-Free
Wednesday, November 19, 2014
A chemically-defined cryopreservation solution for mesenchymal stem cells.

<< 1 2 3 4 5 6 7 >>
Showing Results 1 - 10 of 262
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
SELECTBIO Market Reports
LabTube - Videos for the Scientific Community
eposters - The Online Journal of Scientific Posters
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn